|
General Virology
GENERAL CLASSIFICATION
The viruses are a large group of obligate intracellular parasites capable of infecting a variety of different cell types. Viruses may contain either DNA or RNA as their genomic material and this material may be either single- or double-stranded. Single-stranded genomes may be of positive (i.e. mRNA) or negative (i.e. anti-mRNA) polarity. Surrounding and protecting the genome is a coat of protein ("capsid") arranged in one of several possible morphologies. Certain viruses also contain an additional phospholipid bilayer ("envelope") derived from the host cell and surrounding the protein capsid. This page will discuss the similarities and differences of these biological entities. Some of the viruses that cause disease in humans are described in the following table (or click here to see a viral classification flowchart):
Virus |
Genome |
Polarity |
Segments |
Morphology |
Enveloped |
Diseases |
Picorna |
RNA |
+ss |
1 |
Icosahedral |
No |
Polio, Hepatitis A, Colds |
Toga |
RNA |
+ss |
1 |
Icosahedral |
Yes |
Encephalitis, Rubella |
Retro |
RNA |
+ss |
1+1 |
Icosahedral |
Yes |
AIDS |
Orthomyxo |
RNA |
-ss |
6-8 |
Helical |
Yes |
Influenza |
Rhabdo |
RNA |
-ss |
1 |
Helical |
Yes |
Rabies |
Paramyxo |
RNA |
-ss |
1 |
Helical |
Yes |
Parainfluenza, Mumps, Measles |
Papova |
DNA |
ds |
1 |
Icosahedral |
No |
Warts |
Adeno |
DNA |
ds |
1 |
Icosahedral |
No |
Respiratory Infections |
Herpes |
DNA |
ds |
1 |
Icosahedral |
Yes |
HS, VZ, Mononucleosis, Cancer |
Pox |
DNA |
ds |
1 |
Complex |
Yes |
Smallpox |
Hepatitis B |
DNA |
ds |
1 |
Icosahedral |
Yes |
Serum Hepatitis |
|
MULTIPLICATION
The process of viral multiplication involves several discrete steps. First, the virus must recognize and attach to its host cell. Generally, viruses are limited as to the type of host cell in which they can multiply and so recognition is often very specific. Viruses adsorb to their host cell surface via specific antireceptor molecules, often glycoproteins. Adsorption is generally temperature and energy independent. Penetration into the host cell, however, is often energy dependent and may occur by three different mechanisms; 1) translocation of the plasma membrane, 2) pinocytosis into cytoplasmic vacuoles, or 3) fusion of the plasma membrane with the viral envelope. Non-enveloped viruses may enter via translocation or pinocytosis; enveloped viruses typical enter via fusion. Once inside the host cell, uncoating releases the viral genome to be replicated.
EFFECTS ON HOST CELLS
Viruses can have one of several different effects on their cellular hosts. Abortive infections may result when a virus mistakenly infects a cell that does not permit viral replication. At the other extreme, cytolytic infections lead to cell lysis and release of large numbers of virus. Persistent infections may be productive, latent or transforming. The table to the right outlines some of these effects. |
|
|
|
|
|
|
Type of Effect |
Virus Production |
Fate of Cell |
Abortive |
No |
No Effect |
Cytolytic |
Yes |
Death |
Persistent |
|
|
•Productive |
Yes |
Senescence |
|
•Latent |
No |
No Effect |
|
•Transforming |
|
|
•DNA |
No |
Immortalization |
|
•RNA |
Yes |
Immortalization |
HOST DEFENSES AGAINST VIRAL INFECTION
A number of host defenses contribute to the prevention and/or elimination of viral infections. Nonspecific defenses include (prior to infection) anatomical barriers, viral inhibitors in fluids and tissues. Phagocytosis is somewhat variable. After infection, factors such as fever (viral replication is strongly influenced by temperature) and inflammatory processes including edema, leukocyte accumulation, local hyperthermia, reduced oxygen tension and altered cell metabolism can all act to reduce viral replication. Another important anti-viral factor is interferon. This substance is produced by an infected cell. It then reacts with other cells to i) activate an RNA endonuclease causing mRNA degradation or ii) cause phosphorylation of eIF2, essentially turning off cellular protein synthesis. Specific host defenses include antiviral antibody, which may prevent adsorption to target cells and cytotoxic T-lymphocytes, which recognize virally-infected cells and destroy them, reducing viral production.
|
|